ARCHIVES

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

This article is from The Cancer Letter archive.

Vol. 14 No. 05 | January 29, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts

June 30, 1989